RSS Feeds
Search

Companies

Companies

Displaying 1..10 of 17 - per page Next page
Order by
Profiled on pharmalicensing.com Zambon Company SpA
Zambon Company SpA is a privately-held multinational pharmaceutical and chemical company that looks for in-licensing products in late stage development or already in the market.. More
Profiled on pharmalicensing.com CrystecPharma
CrystecPharma applies the latest supercritical fluid (SCF) technologies to improve the design and performance of medicines More
Profiled on pharmalicensing.com National Jewish Health
The mission of National Jewish Health is to heal, to discover and to educate as a preeminent healthcare institution. More
Decision Resources Inc.
The worldwide leader in market research publications, advisory services and consulting More
LAWSON Business Development
LAWSON HEALTH RESEARCH INSTITUTE is one of Canada's largest hospital-based research institutes. More
Dr.Dozo Laboratories
Novel Innovations in theTreatment of Oncology and Arthritis... More
Apsen Farmacêutica SA
Transforming special needs into big achievements - in urology, rheumatology, gynecology, neurology and other indications More
Bioneer A/S
Bioneer is a CRO research based company within recombinant protein production, immuno-regulatory assays, drug characterization and formulation and diagnostic biomarkers. More
DKFZ (Deutsches Krebsforschungszentrum)
The Deutsche Krebsforschungszentrum (DKFZ) Heidelberg was founded as a non-profit organization and supraregional research center by the Land (state) Baden-Württemberg in 1964. More
Sager Pharma Ltd
Sager Pharma is a leading privately held pharma company licensing in, importing, distributing and marketing pharmaceutical products both in the OTC and Prescription segment of the Hungarian market. More
Displaying 1..10 of 17 - per page Next page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Epidemiology: Rheumatoid Arthritis - Aging populations behind increases in patient populations
Mar 2011 - 23 pages - $5,700
Rheumatoid Arthritis Market Assessment
Sep 2008 - $2,500
Clinical Trial Recruitment in Autoimmune Disorders-Average Patient Recruitment Per Trial has Continued to Decline Over the Past Decade
Sep 2011 - 95 pages - $3,500
Worldwide Market for Rheumatoid Arthritis and Lupus Treatments (Autoimmune Disease Markets)
Jan 2008 - 180 pages - $3,500
Rheumatoid Arthritis Therapy Area Pipeline Report
Nov 2010 - 1168 pages - $1,495
Autoimmune Market Access in China – New biologic therapies drive future growth
Sep 2011 - 87 pages - $5,700
Autoimmune Market Access in India – Market opportunities for cost-effective biosimilars
Aug 2011 - 58 pages - $5,700
Rigel Pharmaceuticals, Inc. - Product Pipeline Review - Q4 2010
Nov 2010 - 61 pages - $500
Rheumatoid Arthritis Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Oct 2011 - 131 pages - $3,500
Musculoskeletal Disorders Therapeutics to 2016 - Introduction of Monoclonal Antibodies with First - in - class Mechanism of Action to Increase Treatment Options in Osteoporosis and Rheumatoid Arthritis
Oct 2010 - 169 pages - $3,500
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us